MBP-1 inhibits breast cancer growth and metastasis in immunocompetent mice

Cancer Research

Volumn 69, Issue 24, 2009, Pages 9354-9359

  Kanda, Tatsuo ^a   Raychoudhuri, Amit ^a   Steele, Robert ^a   Sagartz, John E ^a   West, Cheri ^a   Ray, Ratna B ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS MBP 1; ADENOVIRUS VECTOR; MATRIX METALLOPROTEINASE; MBP 1 PROTEIN; MYC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; C57BL 6 MOUSE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; GENE THERAPY; HUMANS; IMMUNOCOMPETENCE; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC;

EID: 73649086958     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2974     Document Type: Article

References (31)

1. Carter SL, Negrini M, Baffa R, et al. Loss of heterozygosity at 11q22-23 in breast cancer. Cancer Res 1994;54:6270-74.
2. Devilee P, Schuuring E, van de Vijver MJ, Cornelisse CJ. Recent development in the molecular genetic understanding of breast cancer. Crit Rev Oncog 1994;5:247-70.
3. Cox LA, Chen G, Lee EY-HP. Tumor suppressor genes and their roles in breast cancer. Breast Cancer Res Treat 1994;32:19-38.
4. Ellis M, Hayes D, Lippman M. Treatment of metastatic disease. In: Morrow M, editor. Diseases of the breast. Philadelphia: Lippincott-Raven; 2000, p. 749-98.
5. Ray R, Miller DM. Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 1991;11:2154-61.
6. Ray R. Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Cell Growth Differ 1995;6:1089-96.
7. Subramanian A, Miller DM. Structural analysis of α-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 2000;275:5958-65.
8. Ray RB, Sheikh MS, Fontana JF, Miller DM. Human breast carcinoma cells show correlation in expression of c-myc oncogene and the c-myc binding protein (MBP-1). Int J Oncol 1994;5:1433-36.
9. White RA, Adkison LR, Dowler LL, Ray RB. Chromosomal localization of the human gene encoding c-myc promoter-binding protein (MPB1) to chromosome 1p35-pter. Genomics 1997;39:406-8.
10. Giallongo A, Feo S, Moore R, Croce CM, Showe LC. Molecular cloning and nucleotide sequence of a full-length cDNA for human α enolase. Proc Natl Acad Sci U S A 1986;83:6741-5.
11. Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett 2000;473:47-52.
12. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74.
13. Mehta PB, Jenkins BL, McCarthy L, et al. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene 2003;22:1381-89.
14. Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y, Sarkar FH. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-κB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 2006;66:2778-84.
15. Ghosh AK, Majumder M, Steele R, Liu TJ, Ray RB. MBP-1 mediated apoptosis involves cytochrome c release from mitochondria. Oncogene 2002;21:2775-84.
16. Ghosh AK, Steele R, Ray RB. Carboxyl-terminal repressor domain ofMBP-1 is sufficient for regression of prostate tumor growth in nudemice. Cancer Res 2005;65:718-21.
17. Ghosh AK, Steele R, Ryerse J, Ray RB. Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells. Cancer Res 2006;66:11907-12.
18. Fisher PB. Is mda-7/IL-24 a "magic bullet" for cancer? Cancer Res 2005;65:10128-38.
19. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006;6:449-58.
20. Sarkar D, Su ZZ, Vozhilla N, Park ES, Gupta P, Fisher PB. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nudemice. Proc Natl Acad Sci U S A 2005;102:14034-9.
21. Sarkar D, Su ZZ, Park ES, et al. A cancer terminator virus eradicates both primary and distant human melanomas. Cancer Gene Ther 2008;15:293-302.
22. Ewens A, Luo L, Berleth E, et al. Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice. Cancer Res 2006;66:5419-26.
23. Ray RB, Steele R, Seftor E, Hendrix M. Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res 1995;55:3747-51.
24. Overall CM, Kleifeld O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006;6:227-39.
25. Abdollahi A, Lipson KE, Sckell A, et al. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res 2003;63:8890-8.
26. Yi T, Yi Z, Cho SG, et al. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res 2008;68:1843-50.
27. Monami G, Gonzalez EM, Hellman M, et al. Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex. Cancer Res 2006;66:7103-10.
28. Steele RJ, Lane DP. p53 in cancer: a paradigm for modern management of cancer. Surgeon 2005;3:197-205.
29. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
30. Qin H, Sun Y, Benveniste EN. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 1999;274:29130-7.
31. Hsu KW, Hsieh RH, Lee YH, et al. The activated Notch1 receptor cooperates with α-enolase and MBP-1 in modulating c-myc activity. Mol Cell Biol 2008;28:4829-42.